Your browser of choice has not been tested for use with Barchart.com. If you have issues, please download one of the browsers listed here.
Join Barchart Premier to get Screeners that run automatically with the results emailed to you! FREE 30 Day Trial
Stocks | Futures | Watchlist | News | More
or
Faster, Cleaner, Better.

Gh Research Plc (GHRS)

Gh Research Plc (GHRS)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
Profile for [[ item.sessionDateDisplayLong ]]

Company Info

Gh Research Plc JOSHUA DAWSON HOUSE DAWSON STREET DUBLIN L2 D02 RY95 IRL

www.ghres.com Employees: 50 P: 353-1437-8334

Sector:

Medical

Description:

GH Research PLC is a clinical-stage biopharmaceutical company. It dedicated to treat psychiatric and neurological disorders. The company's initial focus is on developing its novel and proprietary 5-MeO-DMT therapies for the treatment of patients with Treatment-Resistant Depression. GH Research PLC is based in DUBLIN.

Key Statistics

Overview:

Market Capitalization, $K 789,004
Enterprise Value, $K 688,214
Shares Outstanding, K 52,028
Float, K 30,384
% Float 58.40%
Short Interest, K 2,542
Short Float 4.89%
Days to Cover 2.32
Short Volume Ratio 0.74
% of Insider Shareholders 41.60%
% of Institutional Shareholders 56.90%

Financials:

Annual Sales, $ 0 K
Annual Net Income, $ -38,960 K
Last Quarter Sales, $ 0 K
Last Quarter Net Income, $ -14,020 K
EBIT, $ -56,940 K
EBITDA, $ -56,620 K

Growth:

1-Year Return 12.25%
3-Year Return 51.20%
5-Year Return 0.00%
5-Year Revenue Growth 0.00%
5-Year Earnings Growth 0.00%
5-Year Dividend Growth 0.00%

Per-Share Information:

Most Recent Earnings -0.23 on 11/06/25
Next Earnings Date 02/26/26 [--]
Earnings Per Share ttm -0.74
EPS Growth vs. Prev Qtr -53.33%
EPS Growth vs. Prev Year 0.00%
Annual Dividend & Yield (Paid) 0.00 (0.00%)
Annual Dividend & Yield (Fwd) 0.00 (0.00%)
Dividend Payout Ratio 0.00%

GHRS Ratios

Ratio
Price/Earnings ttm 0.00
Price/Earnings forward N/A
Price/Earnings to Growth N/A
Return-on-Equity % -15.84%
Return-on-Assets % -15.27%
Profit Margin % 0.00%
Debt/Equity 0.00
Price/Sales N/A
Price/Cash Flow N/A
Price/Book 2.44
Book Value/Share 5.60
Interest Coverage -53.11
60-Month Beta 0.99
Want to use this as
your default charts setting?
Save this setup as a Chart Templates
Switch the Market flag
for targeted data from your country of choice.
Open the menu and switch the
Market flag for targeted data from your country of choice.
Want Streaming Chart Updates?
Switch your Site Preferences
to use Interactive Charts
Need More Chart Options?
Right-click on the chart to open the Interactive Chart menu.
Use your up/down arrows to move through the symbols.
Free Barchart Webinar